AccuraGen, based in San Jose, CA, is a pioneering company in the field of cancer diagnostics, specializing in liquid biopsy technology. Their non-invasive approach to DNA and RNA sequencing offers a comprehensive view of a patient's disease status, making it easily performed at regular intervals and minimizing stress for patients.
With their proprietary technology, AccuraGen ensures a high conversion rate and minimal errors in detecting a wide range of genetic alterations, surpassing industry benchmarks. Their multidisciplinary team of experts in mathematics, statistics, computer science, clinical science, and genomics work together to convert minute cancer signals in the blood into actionable diagnostics-grade information, revolutionizing the future of cancer management.
Generated from the website